Taletrectinib is a Highly Selective ROS1/NTRK Kinase Inhibitor for Solid Tumors Research
The transmembrane proto-oncogene receptor tyrosine kinase (RTK) ROS is one of the last two remaining orphan receptor tyrosine kinases. The ectopic expression, as well as the production of variable mutant…